title: [Smoking and peripheral vascular disorders].
abstract: Smoking is a major risk factor for peripheral arterial occlusive disease (PAOD) and plays a crucial role in the pathogenesis of the thrombangiitis obliterans (TAO), nicotine and carboxyhemoglobin cause functional disturbances and structural damage of the endothelial cells which may initiate arteriosclerosis. Additional effects of smoking are hyperfibrinogenemia, lowering of HDL-cholesterol and increased oxidation of LDL-cholesterol. By these mechanisms, smoking influences other primary risk factors for arteriosclerosis. Patients with PAOD, who continue to smoke, have a worse clinical prognoses with higher amputation and mortality rates than those who quit smoking. The most urgent goal in the therapy of PAOD and TAO should be an immediate and complete smoking cessation. However most patients continue to smoke despite the knowledge of the hazards to their health. An appropriate approach to this addiction may be an alternative application of nicotine temporarily (transdermal by patches or chewing gum) and behavioral treatment. This combined therapy results in better success rates in terms of smoking cessation.
authors.affiliation: Rehabilitationskrankenhaus Karlbsbad-Langensteinbach, Akademisches Lehrkrankenhaus, Universität Heidelberg.
authors.forename: F
authors.initials: F
authors.lastname: Stammler
authors.forename: C
authors.initials: C
authors.lastname: Diehm
mesh_terms: D001157:Arterial Occlusive Diseases / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control; D001161:Arteriosclerosis / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control; D002423:Cause of Death; D006801:Humans; D012907:Smoking / Q000009:adverse effects* / Q000401:mortality; D016540:Smoking Cessation; D013919:Thromboangiitis Obliterans / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control
vernacular_title: Rauchen und periphere Gefässleiden.